hepat
b
viru
hbv
caus
acut
chronic
liver
diseas
includ
fulmin
liver
failur
cirrhosi
hepatocellular
carcinoma
affect
two
billion
world
popul
teo
locarnini
estim
million
individu
chronic
hepat
b
chb
live
high
moder
endem
region
asia
subsharan
africa
eastern
europ
latin
america
hbv
smallest
known
dna
viru
circular
doublestrand
genom
kb
four
overlap
open
read
frame
encod
surfac
envelop
core
c
precor
prece
polymerasereversetranscriptas
polrt
x
protein
beck
nassal
uniqu
hbv
replic
dna
via
rna
intermedi
molecul
reversetranscript
henc
nicknam
pararetroviru
owe
similar
retrovir
replic
mechan
almost
approv
drug
human
immunodefici
viru
hiv
herp
simplex
viru
hsv
prove
effect
hbv
unfortun
despit
high
efficaci
major
approv
antihbv
drug
therapeut
limit
longterm
treatment
hbv
pol
inhibitor
nucleot
ide
analog
eg
lamivudin
adepovir
entecavir
etc
lead
emerg
drugresist
pol
tyrmetaspasp
ymdd
motif
interferon
chemotherapi
caus
advers
sideeffect
patient
lok
et
al
locarnini
et
al
addit
despit
global
success
vaccin
report
vaccineescap
hbv
mutant
present
anoth
hurdl
teo
locarnini
torresi
moreov
lowincom
countri
variou
polit
socioeconom
factor
hamper
prevent
control
chb
tradit
herbal
product
drug
indigen
origin
ancient
histori
cure
sever
chronic
infect
diseas
rang
variou
plant
metabolit
shown
imped
viru
replic
without
affect
host
physiolog
limit
sideeffect
martin
ernst
hussain
et
al
addit
abil
interfer
directli
viral
replic
natur
product
may
also
modul
host
immun
respons
infect
kurokawa
et
al
line
sever
natur
plantderiv
compound
belong
differ
chemic
class
report
potenti
antihbv
activ
chen
et
al
chang
et
al
wang
huang
et
al
chou
et
al
qiu
chen
wu
parvez
et
al
compar
interferon
lamivudin
treatment
plant
product
report
similar
even
better
efficaci
chen
zhu
arbab
et
al
zhang
et
al
interestingli
therefor
approxim
chb
patient
china
reli
tradit
herbal
medicin
hbvreport
cell
line
one
establish
system
preliminari
screen
antihbv
drug
vitro
silico
molecular
dock
tool
enabl
assess
bind
abil
ligand
protein
activesit
well
compar
bind
mode
differ
ligand
activ
sitepocket
leach
therefor
studi
evalu
novel
antihbv
activ
well
delin
mechan
action
select
plantderiv
compound
differ
class
use
cell
cultur
molecular
dock
method
twelv
natur
antivir
compound
plant
origin
select
basi
publish
vitro
vivo
antivir
activ
cell
cultur
grade
natur
compound
viz
rutin
quercetin
menisdaurin
hesperidin
psoralen
bergenin
azadirachtin
baccatin
iii
lupeol
embelin
naringenin
purchas
sigmaaldrich
germani
approv
antihbv
nucleosid
analog
lamivudin
sigmaaldrich
germani
serv
standard
posit
control
hbvreport
cell
human
hepatoblastoma
line
kindli
obtain
dr
jameel
intern
center
genet
engin
biotechnolog
new
delhi
india
cell
maintain
medium
invitrogen
usa
supplement
heatinactiv
bovin
calf
serum
gibco
usa
penicillinstreptomycin
invitrogen
usa
sodium
pyruv
hyclon
laboratori
usa
humidifi
chamber
suppli
compound
first
test
vitro
cytotox
effect
cultur
cell
cell
seed
well
triplic
flatbottom
cultur
plate
bectondickinson
labwar
grown
night
compound
first
dissolv
dimethyl
sulfoxid
dmso
follow
final
prepar
cultur
media
mgml
five
dose
compound
prepar
dilut
cultur
media
final
concentr
dmso
use
never
exceed
therefor
cytotox
rpmi
dmso
serv
untreat
neg
control
cultur
replenish
media
contain
dose
drug
incub
h
follow
mtt
assay
tac
mtt
cell
prolifer
assay
kit
trevigen
per
manufactur
manual
cytotox
concentr
compound
determin
use
regress
curv
excel
softwar
experi
repeat
confirm
reproduc
h
posttreat
cell
visual
monitor
morpholog
chang
like
lesion
cell
membran
compact
cytoplasm
compon
invert
microscop
optica
itali
magnif
cell
seed
flatbottom
well
plate
triplic
incub
overnight
base
cytotox
result
previous
report
assay
treatment
dose
chosen
pure
compound
antihbv
experi
lamivudin
prepar
dmso
rmpi
includ
posit
control
parvez
et
al
rpmi
dmso
serv
untreat
control
next
day
old
media
replac
fresh
media
contain
compound
control
cultur
incub
day
describ
elsewher
arbab
et
al
cultur
supernat
replac
fresh
dose
everi
altern
day
sampl
collect
day
save
viral
hbsag
product
cultur
supernat
analyz
use
monolisa
hbsag
ultra
elisa
kit
biorad
usa
per
manufactur
instruct
data
present
inhibit
hbsag
express
relat
untreat
control
experi
repeat
confirm
reproduc
inhibitori
activ
select
compound
hbv
replic
test
cell
cultur
supernat
sampl
collect
day
analyz
viral
hbeag
synthesi
use
hbeagantihb
elisa
kit
diasourc
belgium
follow
manufactur
instruct
data
present
inhibit
hbeag
express
relat
untreat
control
experi
repeat
confirm
reproduc
quercetin
assess
enhanc
antihbv
effect
combin
baccatin
iii
psoralen
embelin
menisdaurin
azadirachtin
alon
togeth
cultur
supernat
collect
day
analyz
hbeag
synthesi
data
present
rule
inhibitori
effect
test
antivir
compound
hostsynthes
protein
luciferas
assay
perform
describ
previous
aldosari
parvez
briefli
cell
transfect
renillaluciferas
plasmid
prltk
promega
usa
use
promega
usa
cultur
plate
follow
treatment
triplic
compound
includ
dmso
untreat
control
day
incub
ie
day
posttransfect
cell
lysat
prepar
luciferas
express
measur
luciferas
report
assay
system
promega
usa
data
present
relat
neg
control
sequenc
hbv
polrt
genbank
retriev
ncbi
databas
http
wwwncbinlmnihgovgenbank
hbv
amino
acid
residu
respons
pol
activ
daga
et
al
use
queri
search
protein
databas
identif
suitabl
templat
known
xray
crystal
structur
xray
crystal
structur
geneticallyclos
hivrt
pdb
id
select
templat
model
hbv
pol
structur
report
previous
huang
et
al
swiss
model
server
use
predict
threedimension
structur
hbv
pol
arnold
et
al
qualiti
predict
structur
valid
ramachandran
plot
use
rampag
server
lovel
et
al
model
hbv
pol
use
receptor
screen
bind
mode
antivir
natur
compound
includ
lamivudin
fig
autodock
vina
pyrx
virtual
screen
tool
trott
olson
dallakyan
olson
compound
energi
minim
use
univers
forc
field
uff
compound
show
kcalmol
redock
hbv
pol
evalu
detail
bind
mechan
use
autodock
describ
elsewher
morri
et
al
alyousef
et
al
molecular
dock
target
protein
ligand
prepar
describ
elsewher
rehman
et
al
rabbani
et
al
briefli
target
model
protein
hbv
pol
prepar
remov
heterogen
compound
water
molecul
polar
hydrogen
atom
kollman
charg
ad
protein
use
autodock
tool
adt
affin
grid
map
gener
way
cover
complet
activ
site
protein
molecular
dock
perform
use
lamarkian
genet
algorithm
lga
calcul
possibl
conform
ligand
bind
target
protein
ligand
set
free
search
bind
activ
site
protein
favor
minimum
energi
conform
initi
posit
orient
ligand
set
randomli
torsion
set
maximum
run
dock
perform
calcul
energi
evalu
popul
size
translat
step
quaternion
torsion
step
set
respect
basi
bind
energi
best
dock
structur
save
analyz
receptorligand
interact
use
discoveri
studio
accelri
softwar
inc
bind
constant
kb
proteinligand
interact
calcul
use
follow
relat
rehman
et
al
r
ga
constant
calmolk
temperatur
k
data
present
mean
standard
deviat
sd
triplic
experi
normal
untreat
control
analyz
oneway
analysi
varianc
dunnett
ttest
use
calcul
statist
signific
use
excel
softwar
signific
defin
p
p
p
p
rutin
quercetin
menisdaurin
hesperidin
psoralen
bergenin
azadirachtin
baccatin
iii
lupeol
embelin
naringenin
show
sign
cytotox
even
maxim
dose
confirm
microscopi
mtt
assay
investig
antihbv
potenti
select
compound
subject
timecours
day
studi
use
cell
fig
notabl
prolong
treatment
beyond
day
show
signific
effect
continu
cultur
result
cell
overgrowth
death
arbab
et
al
optim
antihbv
activ
day
posttreat
quercetin
baccatin
iii
psoralen
embelin
menisdaurin
azadirachtin
lupeol
rutin
hesperidin
compar
untreat
control
notabl
treatment
maxim
dose
suppress
hbsag
significantli
data
shown
two
compound
bergenin
naringenin
show
effect
inhibit
hbsag
therefor
exclud
antivir
analysi
hbv
secretori
protein
e
antigen
hbeag
process
product
precor
gene
cotransl
core
bicistron
subgenomicrna
therefor
natur
infect
seroposit
hbeag
hallmark
activ
viral
dna
replic
shafritz
lieberman
beck
nassal
notabl
analog
hiv
antigen
elisa
valid
tool
monitor
retrovir
rna
replic
cunningham
et
al
therefor
evalu
antivir
compound
inhibitori
effect
hbeag
product
five
day
fig
notabl
prolong
treatment
beyond
day
show
signific
effect
continu
result
cell
overgrowth
death
data
shown
estim
antivir
activ
compound
day
posttreat
quercetin
baccatin
iii
psoralen
embelin
menisdaurin
azadirachtin
lupeol
rutin
hesperidin
six
compound
quercitin
psoralen
baccatin
iii
menisdaurin
embelin
azadirachtin
show
promis
efficaci
four
lupeol
rutin
hesperidin
moder
antihbv
activ
compar
quercetin
treatment
alon
combin
ww
individu
compound
baccatin
iii
psoralen
embelin
menisdaurin
azadirachtin
enhanc
antivir
activ
fig
howev
enhanc
combinatori
effect
quercetin
use
mixtur
compound
reporterprotein
assay
show
nonsignific
chang
level
renillaluciferas
protein
synthesi
cell
upon
treatment
optim
dose
antihbv
natur
compound
fig
confirm
specif
inhibit
viral
protein
hbsag
hbeag
without
affect
nonviralhost
protein
express
test
compound
hbv
pol
desir
target
protein
develop
potenti
antihbv
nucleot
ide
drug
despit
emerg
drugresist
mutat
pol
ymdd
motif
lok
et
al
locarnini
et
al
sinc
crystal
structur
hbv
pol
avail
use
homolog
model
predict
threedimension
structur
report
amino
acid
residu
determin
revers
transcriptas
activ
hbv
pol
therefor
use
sequenc
queri
search
protein
databas
identif
suitabl
templat
base
primari
sequenc
align
fig
use
rt
pdb
id
templat
hbv
pol
homolog
model
two
viral
protein
demonstr
highli
conserv
residu
import
enzymat
activ
homolog
model
hbv
pol
gener
use
swiss
model
server
fig
valid
ramachandran
plot
ramachandran
plot
show
residu
occupi
favor
region
residu
occupi
allow
gener
allow
region
respect
residu
locat
disallow
outlier
region
fig
overal
ramachandran
plot
suggest
gener
model
hbv
pol
reason
good
qualiti
therefor
use
molecular
dock
lamivudin
fig
first
gener
nucleot
idebas
antiretrovir
drug
gener
use
treatment
hivaid
chb
dock
lamivudin
control
hbv
pol
indic
bound
activ
site
mainli
hydrophob
alkyl
interact
interact
strongli
hbv
pol
form
four
hydrophob
interact
fig
also
form
one
convent
hydrogen
bond
two
carbonhydrogen
bond
residu
surround
lamivudin
well
ymdd
motif
molecular
dock
studi
reveal
lamivudinehbv
pol
complex
stabil
estim
free
energi
kcalmol
correspond
bind
affin
tabl
lupeol
fig
interact
hbv
pol
form
four
alkyl
hydrophob
interact
six
pialkyl
hydrophob
interact
fig
residu
surround
lupeol
gibb
free
energi
lupeolpol
interact
predict
kcalmol
correspond
bind
constant
tabl
psoralen
fig
interact
hbv
pol
form
one
hydrogen
bond
two
hydrogen
bond
also
form
one
picat
electrostat
interact
notabl
also
involv
form
one
pipi
tshape
hydrophob
interact
psoralen
moreov
complex
psoralen
hbv
pol
stabil
one
pialkyl
hydrophob
interact
form
three
pialkyl
hydrophob
interact
fig
residu
surround
psoralen
gibb
free
energi
psoralenpol
interact
predict
kcalmol
correspond
bind
constant
tabl
menisdaurin
fig
interact
hbv
pol
form
three
hydrogen
bond
also
form
one
alkyl
hydrophob
interact
fig
residu
surround
menisdaurin
ymdd
motif
gibb
free
energi
menisdaurinpol
interact
predict
kcalmol
correspond
bind
constant
tabl
hesperidin
fig
interact
hbv
pol
form
seven
hydrogen
bond
one
carbon
hydrogen
bond
fig
also
form
two
pipi
stack
hydrophob
interact
one
alkyl
hydrophob
interact
one
pialkyl
hydrophob
interact
residu
surround
hesperidin
gibb
free
energi
hesperidinhbv
pol
interact
predict
kcalmol
correspond
bind
constant
tabl
azadirachtin
fig
bound
activ
site
hbv
pol
four
hydrogen
bond
fig
also
form
one
carbon
hydrogen
bond
moreov
complex
azadiractin
hbv
pol
stabil
three
hydrophob
interact
residu
surround
azadiractin
gibb
free
energi
azadirachtinpol
interact
found
kcalmol
correspond
bind
constant
tabl
rutin
fig
also
bind
activ
site
hbv
pol
form
seven
hydrogen
bond
fig
also
form
two
electrostat
interact
pianion
one
hydrophob
interact
pialkyl
residu
surround
rutin
notabl
rutin
interact
ymdd
motif
hbv
pol
gibb
free
energi
rutinpol
interact
predict
kcalmol
correspond
bind
constant
tabl
fig
interact
hbv
pol
form
one
pisigma
hydrophob
interact
five
alkyl
hydrophob
interact
ten
pialkyl
hydrophob
interact
fig
residu
surround
gibb
free
energi
interact
found
kcalmol
correspond
bind
constant
tabl
quercetin
fig
bind
activ
site
hbv
pol
form
nine
hydrogen
bond
fig
also
form
two
picat
one
pianion
electrostat
interact
form
two
hydrophob
interact
pialkyl
residu
surround
quercetin
ymdd
motif
gibb
free
energi
quercetinpol
interact
predict
kcalmolwhich
correspond
bind
constant
tabl
embelin
fig
interact
hbv
pol
form
three
hydrogen
bond
also
form
one
alkyl
hydrophob
interact
three
pialkyl
hydrophob
interact
fig
residu
surround
embelin
gibb
free
energi
embelinpol
interact
predict
kcalmol
correspond
bind
constant
tabl
baccatin
iii
fig
interact
hbv
pol
form
three
hydrogen
bond
also
form
two
carbon
hydrogen
bond
addit
one
alkyl
hydrophob
interact
fig
residu
surround
baccatin
iii
interestingli
baccatin
iii
also
interact
ymdd
motif
hbv
pol
gibb
free
energi
baccatin
iiipol
interact
predict
kcalmol
correspond
bind
constant
tabl
past
decad
antivir
drug
research
technolog
help
establish
mani
efficaci
antihbv
drug
eventu
lead
emerg
drugresist
strain
henc
new
antivir
strategi
must
focu
synthet
molecul
also
potenti
natur
plant
product
antivir
drug
discoveri
develop
pass
sever
stage
vitro
cell
cultur
system
silico
molecular
model
repres
first
fastest
drug
screen
step
absenc
robust
cell
cultur
system
propag
hbv
imped
vitro
antivir
studi
advent
hbv
dna
clone
establish
stabl
cell
line
hbvreport
cell
line
one
establish
system
preliminari
screen
antihbv
drug
present
studi
antihbv
potenti
specif
select
natur
compound
assess
inhibitori
effect
hbsag
hbeag
express
cultur
supernat
quercetin
psoralen
baccatin
iii
menisdaurin
embelin
azadirachtin
show
high
activ
wherea
lupeol
rutin
hesperidin
moder
efficaci
hbv
replic
hbv
pol
import
viral
protein
potenti
drugtarget
despit
emerg
drugresist
mutat
around
polrt
ymdd
motif
locarnini
et
al
use
homolog
model
gener
structur
hbv
pol
valid
ramachandran
plot
wherein
ymdd
correspond
residu
delin
bind
mechan
antihbv
activ
compound
lamivudin
ligand
model
hbv
pol
receptor
perform
molecular
dock
dock
lamivudin
indic
strongli
interact
activ
site
hbv
pol
bond
form
stabl
lamivudinepol
complex
estim
gibb
free
energi
kcalmol
interestingli
therein
two
pol
ymdd
motif
residu
among
lamivudin
surround
amino
acid
quercetin
wide
distribut
plant
flavonol
report
vitro
antivir
activ
meningoviru
hsv
hiv
parainfluenza
type
pseudorabi
viru
respiratori
syncyti
viru
rsv
sindbi
viru
kaul
et
al
mucsi
vrijsen
et
al
choi
et
al
kelli
chiow
et
al
though
singl
studi
shown
antihbv
potenti
vitro
cheng
et
al
mechan
action
report
line
vitro
data
confirm
high
antihbv
potenti
quercetin
dock
quercetin
hbv
pol
reveal
format
bond
stabil
quercetinpol
complex
estim
free
energi
kcalmol
notabl
therein
belong
pol
ymdd
motif
among
quercetin
surround
residu
psoralen
natur
caumarin
recent
report
inhibit
viru
ebv
kaposi
sarcomaassoci
herpesviru
kshv
replic
cho
et
al
add
data
present
novel
antivir
potenti
psoralen
hbv
replic
molecular
dock
show
interact
psoralen
hbv
pol
stabl
psoralenpol
complex
free
energi
kcalmol
baccatin
iii
isol
needl
pacif
yew
tree
synthet
avail
iii
baccatin
iii
wide
assum
inact
deriv
taxol
isol
taxu
brevifolia
bark
though
singl
vitro
studi
baccarin
iii
shown
antihsv
activ
noncytotox
dose
krawczyk
et
al
mechan
action
known
conform
result
first
time
show
high
antihbv
activ
baccatin
iii
dock
baccatin
iii
hbv
pol
show
interact
residu
form
baccatinpol
complex
free
energi
kcalmol
notabl
ymdd
motif
among
baccatin
iii
surround
amino
acid
menisdaurin
plant
cyanoglycosid
limit
inform
antivir
activ
two
report
antihbv
activ
menisdaurin
isol
saniculiphyllum
guangxiens
geng
et
al
mangrov
bruguiera
gymnorrhiza
yi
et
al
recent
publish
line
data
endors
vitro
antihbv
potenti
contrarili
howev
studi
menisdaurin
activ
lesser
compar
report
higher
activ
lamivudin
yi
et
al
dock
analysi
menisdaurinhbv
pol
interact
predict
free
energi
kcalmol
notabl
therein
one
pol
ymdd
residu
among
menisdaurin
surround
amino
acid
activ
principl
embelia
schimperi
embelin
shown
inhibit
hepat
c
viru
hcv
serin
proteas
activ
hussein
et
al
report
vitro
assess
reveal
novel
antivir
properti
embelin
hbv
molecular
dock
embelin
form
complex
hbv
pol
estim
free
energi
kcalmol
azadirachtin
secondari
metabolit
indian
neem
azadirachta
indica
singl
report
neem
leav
extract
show
inhibit
dengu
viru
dnv
replic
pure
azadirachtin
reveal
inhibitori
effect
vitro
vivo
parida
et
al
report
demonstr
novel
antihbv
activ
azadirachtin
dock
studi
show
interact
azadiractin
hbv
pol
result
stabl
azadiractinpol
complex
free
energi
kcalmol
though
triterpenoid
lupeol
shown
weak
antivir
activ
sever
studi
lupeol
isol
strobilanth
cusia
root
demonstr
robust
antihsv
activ
vitro
flekhter
et
al
therefor
serv
lead
drug
gener
effect
compound
hsv
influenza
zheng
et
al
line
antivir
activ
show
moder
antihbv
potenti
lupeol
vitro
silico
analysi
lupeol
interact
hbv
pol
stabil
lupeolpol
complex
free
energi
kcalmol
rutin
wellknown
therapeut
flavonol
report
vitro
antivir
activ
avian
influenza
viru
murin
noroviru
mnv
carvalho
et
al
ibrahim
et
al
et
al
recent
demonstr
antihbv
activ
g
senegalensi
leav
extract
high
content
rutin
arbab
et
al
alam
et
al
though
moder
antihbv
activ
rutin
present
studi
strongli
support
previou
find
subject
dock
rutin
interact
hbv
pol
form
bond
residu
rutinpol
complex
show
free
energi
kcalmol
notabl
therein
asp
ymdd
residu
among
rutin
surround
amino
acid
plant
shown
exhibit
vitro
vivo
antihiv
activ
bouic
recent
antivir
effect
isol
cottonse
oil
tobacco
mosaic
viru
tmv
also
report
zhao
et
al
first
report
show
vitro
antihbv
activ
support
silico
analysi
interact
hbv
pol
free
energi
complex
kcalmol
hespiridin
flavonoid
limit
knowledg
antivir
activ
watersolubl
deriv
hesperidin
glucosyl
hesperidin
report
vitro
inhibitori
activ
human
avian
influenza
virus
saha
et
al
present
data
demonstr
novel
antihbv
potenti
hesperidin
molecular
dock
hesperidin
form
bond
hesperidinpol
complex
free
energi
kcalmol
present
studi
vitro
antihbv
assess
plantderiv
noncytotox
compound
show
promis
inhibitori
effect
hbsag
hbeag
express
quercetin
baccatin
iii
psoralen
embelin
menisdaurin
azadirachtin
show
high
antihbv
activ
wherea
lupeol
rutin
hesperidin
moder
effect
moreov
combin
quercetin
highli
activ
compound
enhanc
therapeut
efficaci
support
silico
molecular
dock
analysi
test
antihbv
molecul
strongli
interact
model
hbv
pol
activ
site
residu
taken
togeth
data
suggest
novel
antihbv
potenti
natur
compound
viral
polrtinhibitor
nonetheless
experiment
preclin
studi
activ
compound
warrant
author
declar
conflict
interest
